Amanote Research
Register
Sign In
Moclobemide and Selegeline in the Treatment of Depression in Parkinson's Disease
Journal of Neurology, Neurosurgery and Psychiatry
- United Kingdom
doi 10.1136/jnnp.63.4.547
Full Text
Open PDF
Abstract
Available in
full text
Categories
Psychiatry
Mental Health
Neurology
Surgery
Date
October 1, 1997
Authors
E. N H J. STEUR
L. A P BALLERING
Publisher
BMJ
Related search
Depression in Parkinson's Disease
Nevrologiya, Neiropsikhiatriya, Psikhosomatika
Psychiatry
Clinical Psychology
Mental Health
Neurology
Potential Mechanisms Underlying Anxiety and Depression in Parkinson's Disease: Consequences of L-Dopa Treatment
Neuroscience and Biobehavioral Reviews
Physiological Psychology
Neuropsychology
Behavioral Neuroscience
Cognitive Neuroscience
Parkinson's Disease and Depression: Psychometric Properties of the Beck Depression Inventory.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Bromocriptine Treatment in Parkinson's Disease.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Depression in Patients With Parkinson's Disease With Dementia
SANAMED
Management of Depression in Parkinson's Disease: A Systematic Review
Movement Disorders Clinical Practice
Neurology
The Impact of Treatment of Depression on Quality of Life, Disability and Relapse in Patients With Parkinson's Disease
Movement Disorders
Neurology
Treatment of Parkinson's Disease
New England Journal of Medicine
Medicine
Treatment of Parkinson's Disease
New England Journal of Medicine
Medicine
